It is designed for controlled laboratory, research, and industrial applications where a consistent aqueous solvent is required
Vitamin B12 belongs to the water-soluble group
Study 5: Phase 2b clinical study, failure in obesity Citation: Metabolic Pharmaceuticals Phase 2b trial (2007), not fully published
The free B12 binds to a protein called R-binder (haptocorrin) in the stomach
Notably, it targets specific adipose tissue areas, making it a prospective solution for localized fat reduction, a phenomenon commonly referred to as spot reduction. This attribute has piqued the interest of both the cosmetic and fitness industries, where targeted fat loss is a desirable outcome
Compounded medications are not subject to FDA approval and lack the same safety and efficacy data as FDA-approved commercial medications